These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29944240)

  • 21. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
    Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
    J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy Outcome of Women with Chronic Hepatitis B who Discontinued Antiviral Treatment before or in the Early Pregnancy.
    Gao X; Duan X; Cai H; Hu Y; Liu M; Kang K; Zhou M; Fu D; Yi W
    Int J Med Sci; 2020; 17(2):170-175. PubMed ID: 32038100
    [No Abstract]   [Full Text] [Related]  

  • 23. Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission.
    Sun W; Zhao S; Ma L; Hao A; Zhao B; Zhou L; Li F; Song M
    BMC Gastroenterol; 2017 Apr; 17(1):51. PubMed ID: 28407735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus.
    Greenup AJ; Tan PK; Nguyen V; Glass A; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Jackson K; Locarnini SA; Levy MT
    J Hepatol; 2014 Sep; 61(3):502-7. PubMed ID: 24801414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.
    Evans AA; Cohen C; Huang P; Qian L; London WT; Block JM; Chen G
    Vaccine; 2015 Jun; 33(26):3010-5. PubMed ID: 25698491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
    He T; Bai Y; Cai H; Ou X; Liu M; Yi W; Jia J
    Hepatol Int; 2018 Mar; 12(2):118-125. PubMed ID: 29344772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term efficacy and safety of telbivudine in the treatment of childbearing patients with chronic hepatitis B].
    Zhou Y; Zheng J; Pan H; Lu C
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):573-6. PubMed ID: 25243955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of lamivudine treatment in late pregnancy with high HBV DNA: a perspective for mother and infants.
    Köse S; Türken M; Devrim I; Taner C
    J Infect Dev Ctries; 2011 Apr; 5(4):303-6. PubMed ID: 21537073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.
    Eke AC; Eleje GU; Eke UA; Xia Y; Liu J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008545. PubMed ID: 28188612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic HBV: which pregnant women should be treated?
    He T; Jia J
    Liver Int; 2016 Jan; 36 Suppl 1():105-8. PubMed ID: 26725906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of tenofovir in preventing mother-to-infant transmission of hepatitis B virus: a meta-analysis based on 6 studies from China and 3 studies from other countries.
    Li W; Jia L; Zhao X; Wu X; Tang H
    BMC Gastroenterol; 2018 Aug; 18(1):121. PubMed ID: 30071845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial.
    de Niet A; Jansen L; Stelma F; Willemse SB; Kuiken SD; Weijer S; van Nieuwkerk CMJ; Zaaijer HL; Molenkamp R; Takkenberg RB; Koot M; Verheij J; Beuers U; Reesink HW
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):576-584. PubMed ID: 28522204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads.
    Xu J; Tao LL; Ma LX
    J Med Virol; 2019 Dec; 91(12):2153-2157. PubMed ID: 31397488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them.
    Seo KI; Bae SH; Sung PS; Park CH; Lee HL; Kim HY; Kim HJ; Jang BH; Jang JW; Yoon SK; Choi JY; Park IY; Lee J; Lee HS; Kim SJ; Kwon JH; Chang UI; Kim CW; Jo SH; Lee Y; Tekle F; Kim JH
    Clin Mol Hepatol; 2018 Dec; 24(4):374-383. PubMed ID: 29940720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
    Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC;
    Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
    Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
    [No Abstract]   [Full Text] [Related]  

  • 37. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review.
    Tavakolpour S; Darvishi M; Mirsafaei HS; Ghasemiadl M
    Infect Dis (Lond); 2018 Feb; 50(2):95-106. PubMed ID: 29020844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Tripoli, Libya.
    El-Magrahe H; Furarah AR; El-Figih K; El-Urshfany S; Ghenghesh KS
    J Infect Dev Ctries; 2010 Mar; 4(3):168-70. PubMed ID: 20351458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Impact of cessation of antiviral therapy at delivery on postpartum liver function in mothers with chronic hepatitis B virus infection].
    Guo HJ; Gao YF; Liu HY; He HT; Huang MT; Cai DC; Liao DD; Li JN; Yin XR; Liu ZH; Hu J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):112-117. PubMed ID: 30818915
    [No Abstract]   [Full Text] [Related]  

  • 40. [A randomized controlled study on factors influencing the curative effect of sequential combined interferon and lamivudine therapy in children with immune-tolerant phase chronic hepatitis B].
    Zhu SS; Dong Y; Zhang HF; Wang LM; Xu ZQ; Zhang M; Gan Y; Chen DW; Wang FC; Yan JG; Zhao P
    Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):604-609. PubMed ID: 31594077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.